we provide the first evidence that de-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses the apoptosis of CML cells, targeting this pathway might be a promising therapeutic approach for the treatment of CML. This evidence concerns the gene USP15 and chronic myelogenous leukemia, BCR-ABL1 positive.